html { overflow: visible; height: auto; } .MainNav_ItemWrapper:hover .Subnavigation_Wrapper, .MainNav_Item:focus + .Subnavigation_Wrapper { display: block; } .Header-FixedHeight .Dialoog, .Header-FixedHeight .Title_Wrapper, .Accordion_ContentContainer.Hidden { height: auto !important; visibility: visible; } .Dialoog_Step.Invisible, .Title_Wrapper.Invisible, main.Invisible, .js-GridItem { transform: none; opacity: 1; } .Dialoog_Form, .js-OptionsOpenBtn, .Image_Wrapper-Scaled, .Video_Wrapper-Scaled, img[data-src] { display: none; } .js-MasonryGrid { display: flex; flex-wrap: wrap; }

ADRB2 - effectivity medication (pharmacogenetics)

Turnaround time
Complete analysis & Targeted analysis: 1.5 week

Method

Targeted analysis of one or more variants

Remarks
Genetic analysis of the c.46G>A (rs1042713) variant in ADRB2.

OMIM: 600807
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane

GEN

complete analysis

targeted analysis of a familial mutation

€ 320

Add Update Remove

Go to main content

- Wijzig taal in Nederlands ( NL )

Go to Radboudumc website

- Radboudumc & MaasrichtUMC+

Products

Welcome to our new website! Find and order your test(s) of interest

[Type here]

Conditions

My account

This website uses cookies. Read more about cookies.